Drugs / siLR4A
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06138964 | Nov 2023 → Nov 2024 | keloid | National Skin Centre | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | siLR4A | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06138964 ↗ |
| Action | Inhibit | “Small Interfering RNA Against SPARC and IL4-RA (siSPARC + siLR4A) Microneedle Patch” NCT06138964 ↗ |
| Target | IL4R | “Small Interfering RNA Against SPARC and IL4-RA (siSPARC + siLR4A) Microneedle Patch” NCT06138964 ↗ |